YahooOctober 21, 2026 at 8:26 AM NY6 Days Ago
BSX Set to Report Q3 Earnings: Will MedSurg Strength Aid Performance?
Boston Scientific's Q3 results hinge on MedSurg strength in Endoscopy and Neuromodulation, as Cardiovascular faces competitive pressures and softer sales.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
